
United Kingdom · Telecommunications startup
Eseye, founded in 2007, specializes in end-to-end integrated IoT cellular connectivity solutions.
Funding reportedLast round: Series B
Follow Eseye and see its new rounds in your feed.Start following
Eseye, founded in 2007, specializes in end-to-end integrated IoT cellular connectivity solutions.
The company simplifies global IoT deployments with its innovative eSIM localization technology and an agnostic virtual cellular network approach, ensuring near 100% uptime for its clients. Eseye has a strong international presence, with offices in the UK, US, and Brazil, where it is recognized as a leading IoT-specialized Mobile Virtual Network Operator (MVNO). The company's product offerings include the AnyNet+ eSIM, which provides secure and flexible connectivity, and a Connectivity Management Platform that streamlines IoT connection management across various networks. Eseye's "Device-First" approach optimizes connectivity for reliability from concept to execution. Esteemed by analysts, Eseye was named a Visionary in the 2023 Gartner Magic Quadrant for Managed IoT Connectivity Services Worldwide, highlighting its commitment to delivering exceptional IoT solutions.
Funding, as reported
Eseye filed 2 raises, $489K in all. Filings say how much was sold and to how many investors; they never name the investors.
From Eseye's own website: 2 founders, 4 on the team.
What they build
Known for
health careglobal iot solutionsscalable iot solutionsiot device certification supportglobal iotiot connectivityprototyping servicesglobal coverageenvironmental monitoring iotiot for agricultureglobal iot deploymentsglobal roaming solutionsdistributionhigh availability iotcomputer & network securityiot analytics
Built with from their website
WistiaGoogle Tag ManagerAmazon CloudFrontWordPress.orgHREF LangAWS Trusted AdvisorAtlassianPostmarkFont AwesomeApache
Salesforce Lightning Web ComponentsMailChimpCloudFlareViewport MetaCSSSite KitWP EngineBabel
Add your raise, your deck and your story, and put Eseye in front of investors. Or tell us what we have wrong.